Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2017

Dec 13, 2017

29745_dirs_2017-12-13_fd3125a4-b8b4-45b5-b1b6-cace99be1fec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-12-11

Reporting Person: Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-12-11 Restricted Stock Unit $ A 34615 Acquired 2021-12-11 Common Stock (34615.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 114217 Direct
Common Stock 5048 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.